DEPDC5 and Hepatic steatosis: After Torin 1 administration, liver-weight-to-body-weight ratios, liver triglyceride levels and serum ALT levels showed dramatic recovery, indicating that sustained hepatic mTORC1 activation is indeed the major cause of hepatic steatosis observed in Depdc5-LKO mice (Fig. 5C–F).